BioNTech

U.S. Allows Emergency COVID-19 Vaccine in Bid to End Pandemic

The U.S. has given the final go-ahead to the nation’s first COVID-19 vaccine, launching emergency vaccinations in a bid to end the pandemic. Shots will begin in a few days after Friday’s decision by the Food and Drug Administration. The FDA called the vaccine from Pfizer and its German partner BioNTech safe and strongly protective. But initial doses are scarce…

Pfizer Seeking Emergency Use of its COVID-19 Vaccine in the U.S

Pfizer is set to ask U.S. regulators to allow emergency use of its COVID-19 vaccine, starting a process that could bring first shots as early as next month. Friday’s step comes days after Pfizer and its German partner BioNTech announced its vaccine appears 95% protective in a large but not yet finished study. Over the next few weeks, the Food…